|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenues | |
| Cost of revenues | |
| Gross profit | |
| Operating expenses: | |
| Sales, general and administrative | |
| Research and development | |
| Total operating expenses | |
| Operating loss | |
| Other (expense) income: | |
| Interest expense | |
| Interest income | |
| Change in fair value of derivative liabilities | |
| Loss on issuance of convertible note | |
| Other (expense) income, net | |
| Total other (expense) income | |
| Net loss | |
| Basic net loss per common share (in Dollars per share) | |
| Diluted net loss per common share (in Dollars per share) | |
| Weighted-average common shares outstanding, basic (in Shares) | |
| Weighted-average common shares outstanding, diluted (in Shares) |
Loading...
